55 related articles for article (PubMed ID: 8575863)
1. Effect of combination of suboptimal concentrations of P-glycoprotein blockers on the proliferation of MDR1 gene expressing cells.
Hwang M; Ahn CH; Pine PS; Yin JJ; Hrycyna CA; Licht T; Aszalos A
Int J Cancer; 1996 Jan; 65(3):389-97. PubMed ID: 8575863
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in MDR1 expressing cells by daunorubicin with combinations of suboptimal concentrations of P-glycoprotein modulators.
Aszalos A; Ladányi A; Bocsi J; Szende B
Cancer Lett; 2001 Jun; 167(2):157-62. PubMed ID: 11369136
[TBL] [Abstract][Full Text] [Related]
3. Combinations of P-glycoprotein blockers, verapamil, PSC833, and cremophor act differently on the multidrug resistance associated protein (MRP) and on P-glycoprotein (Pgp).
Aszalos A; Thompson K; Yin JJ; Ross DD
Anticancer Res; 1999; 19(2A):1053-64. PubMed ID: 10368654
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacological control of P-glycoprotein expression].
Muller C; Bailly JD; Jaffrezou JP; Goubin F; Laurent G
Bull Cancer; 1994 May; 81(5):386-91. PubMed ID: 7749215
[TBL] [Abstract][Full Text] [Related]
5. Atypical multi-drug resistance (MDR): low sensitivity of a P-glycoprotein-expressing human T lymphoblastoid MDR cell line to classical P-glycoprotein-directed resistance-modulating agents.
Jachez B; Loor F
Anticancer Drugs; 1993 Dec; 4(6):605-15. PubMed ID: 7905300
[TBL] [Abstract][Full Text] [Related]
6. The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor.
Friche E; Jensen PB; Sehested M; Demant EJ; Nissen NN
Cancer Commun; 1990; 2(9):297-303. PubMed ID: 1976341
[TBL] [Abstract][Full Text] [Related]
7. Potential role for human P-glycoprotein in the transport of lacosamide.
Zhang C; Chanteux H; Zuo Z; Kwan P; Baum L
Epilepsia; 2013 Jul; 54(7):1154-60. PubMed ID: 23551115
[TBL] [Abstract][Full Text] [Related]
8. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
Vilpo J; Koski T; Vilpo L
Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
[TBL] [Abstract][Full Text] [Related]
9. Iodination increases the activity of verapamil derivatives in reversing PGP multidrug resistance.
Barattin R; Gerby B; Bourges K; Hardy G; Olivares J; Boutonnat J; Arnoult C; D'Hardemare AD; Ronot X
Anticancer Res; 2010 Jul; 30(7):2553-9. PubMed ID: 20682982
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
[TBL] [Abstract][Full Text] [Related]
11. Effect of PSC 833, verapamil and amiodarone on adriamycin toxicity in cultured rat cardiomyocytes.
Estevez MD; Wolf A; Schramm U
Toxicol In Vitro; 2000 Feb; 14(1):17-23. PubMed ID: 10699357
[TBL] [Abstract][Full Text] [Related]
12. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
[TBL] [Abstract][Full Text] [Related]
13. The effects of anticancer drugs in combination with nimodipine and verapamil on cultured cells of glioblastoma multiforme.
Durmaz R; Deliorman S; Uyar R; Işiksoy S; Erol K; Tel E
Clin Neurol Neurosurg; 1999 Dec; 101(4):238-44. PubMed ID: 10622452
[TBL] [Abstract][Full Text] [Related]
14. Direct interaction between verapamil and doxorubicin causes the lack of reversal effect of verapamil on P-glycoprotein mediated resistance to doxorubicin in vitro using L1210/VCR cells.
Breier A; Drobná Z; Barancík M
Neoplasma; 1998; 45(4):248-53. PubMed ID: 9890669
[TBL] [Abstract][Full Text] [Related]
15. Chalcogenopyrylium dyes as inhibitors/modulators of P-glycoprotein in multidrug-resistant cells.
Sawada GA; Raub TJ; William Higgins J; Brennan NK; Moore TM; Tombline G; Detty MR
Bioorg Med Chem; 2008 Nov; 16(22):9745-56. PubMed ID: 18849167
[TBL] [Abstract][Full Text] [Related]
16. Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine-sirolimus interaction.
Anglicheau D; Pallet N; Rabant M; Marquet P; Cassinat B; Méria P; Beaune P; Legendre C; Thervet E
Kidney Int; 2006 Sep; 70(6):1019-25. PubMed ID: 16837925
[TBL] [Abstract][Full Text] [Related]
17. Influence of antipsychotic, antiemetic, and Ca(2+) channel blocker drugs on the cellular accumulation of the anticancer drug daunorubicin: P-glycoprotein modulation.
Ibrahim S; Peggins J; Knapton A; Licht T; Aszalos A
J Pharmacol Exp Ther; 2000 Dec; 295(3):1276-83. PubMed ID: 11082465
[TBL] [Abstract][Full Text] [Related]
18. Selective modulation of P-glycoprotein-mediated drug resistance.
Bebawy M; Morris MB; Roufogalis BD
Br J Cancer; 2001 Dec; 85(12):1998-2003. PubMed ID: 11747345
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression.
Cordobes MD; Starzec A; Delmon-Moingeon L; Blanchot C; Kouyoumdjian JC; Prévost G; Caglar M; Moretti JL
J Nucl Med; 1996 Feb; 37(2):286-9. PubMed ID: 8667063
[TBL] [Abstract][Full Text] [Related]
20. MDR expression in normal tissues. Pharmacologic implications for the clinical use of P-glycoprotein inhibitors.
Lum BL; Gosland MP
Hematol Oncol Clin North Am; 1995 Apr; 9(2):319-36. PubMed ID: 7642466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
